Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders.

CONCLUSION: Clinical trials with strong methodologies and appropriate doses of melatonin are necessary to support or reject the usefulness of melatonin in neurological diseases.
PMID: 28721826 [PubMed - as supplied by publisher]

Source: Current Medicinal Chemistry - July 18, 2017 Category: Chemistry Authors: Sánchez-Barceló EJ, Revilla NR, Mediavilla MD, Martínez-Cué C, Reiter RJ Tags: Curr Med Chem Source Type: research